# Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease

> **NCT03419806** · PHASE1 · COMPLETED · sponsor: **Vastra Gotaland Region** · enrollment: 25 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Infudopa i.v.
- **DRUG:** Infudopa s.c.
- **DRUG:** LCIG (Duodopa)

## Key facts

- **NCT ID:** NCT03419806
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-16
- **Primary completion:** 2020-03-27
- **Final completion:** 2020-04-20
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-11-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03419806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03419806, "Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03419806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*